Life sciences company Avantor (NYSE:AVTR) will be reporting earnings tomorrow before market hours. Here’s what you need to know. Avantor missed analysts’ revenue expectations by 0.7% last ...
Bernstein analyst Eve Burstein lowered the firm’s price target on Avantor (AVTR) to $22 from $24.50 and keeps a Market Perform rating on the shares following quarterly results. The firm says the ...
Wells Fargo analyst Brandon Couillard maintained a Buy rating on Avantor (AVTR – Research Report) today and set a price target of $28.00. The company’s shares closed last Friday at $19.16.
Revenue: US$6.78b (down 2.6% from FY 2023). Net income: US$711.5m (up 122% from FY 2023). Profit margin: 11% (up from 4.6% in FY 2023). EPS: US$1.05 (up from US$0.47 in FY 2023). Revenue was in ...
Avantor reported Q4 net sales of $1.69 billion, down 2% YoY, missing estimates. Adjusted EPS was $0.27, beating the consensus of $0.26. Net income surged to $500.4 million. The company forecasts ...
Avantor beat estimated earnings by 4.0%, reporting an EPS of $0.27 versus an estimate of $0.26. Revenue was down $35.80 million from the same period last year. The company beat on EPS by $0.01 in ...
(RTTNews) - Avantor, Inc (AVTR) released a profit for its fourth quarter that increased from the same period last year and beat the Street estimates. The company's earnings totaled $500.4 million ...
Avantor has a 12 month low of $19.59 and a 12 month high of $28.00. The stock has a 50 day moving average of $21.71 and a 200-day moving average of $23.47. The company has a market capitalization ...
Michael Stubblefield, CEO, highlighted Avantor's return to growth in Q4 2024 with low single-digit organic growth and strong bioprocessing performance, achieving high single-digit organic growth ...
Caterpillar and PayPal are among the stocks that fell into undervalued territory. We sell different types of products and services to both investment professionals and individual investors. These ...
Avantor, Inc. has a fifty-two week low of $19.59 and a fifty-two week high of $28.00. The firm’s 50 day moving average price is $21.60 and its two-hundred day moving average price is $23.45.
(RTTNews) - Avantor, Inc. (AVTR), a biotechnology, chemicals, and pharmaceuticals company, Friday announced a surge in net income for the fourth quarter, from the prior year. Shares of Avantor are ...